Copyright
©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 166-186
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Ref. | Procedure | Patients, n | Technical success % | Morbidity % |
Artifon et al[50], 2012 | PTBD, EUS-BD | 12, 13 | 100, 100 | 25.00, 15.30 |
Bapaye et al[51], 2013 | PTBD, EUS-BD | 26, 25 | 46.00, 92.00 | 46.00, 20.00 |
Khashab et al[52], 2015 | PTBD, EUS-BD | 51, 22 | 100, 86.40 | 39.20, 18.20 |
Dhir et al[53], 2015 | ERCP SEMS, EUS-BD | 104, 104 | 94.23, 93.26 | 8.65, 8.65 |
- Citation: Tantau AI, Mandrutiu A, Pop A, Zaharie RD, Crisan D, Preda CM, Tantau M, Mercea V. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies. World J Hepatol 2021; 13(2): 166-186
- URL: https://www.wjgnet.com/1948-5182/full/v13/i2/166.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i2.166